US Map / Oregon
State OR

Clinical Trials in Oregon

Oregon is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Oregon and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 195 actively recruiting studies with Oregon sites out of 195 registered in total. The busiest research areas in Oregon are Breast Cancer, Endometrial Cancer, Advanced Solid Tumor. Leading sponsors running trials in the state include Oregon Health and Science University, National Cancer Institute (NCI), VA Office of Research and Development. By stage, Oregon trials break down as Phase 1 (25), Phase 2 (49), Phase 3 (55), Phase 4 (5).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
195
Recruiting Now
195
← Back to US Map
Top Conditions in Oregon
Breast Cancer (7)Endometrial Cancer (6)Advanced Solid Tumor (5)Ovarian Cancer (4)Colorectal Cancer (4)Multiple Myeloma (4)Metastatic Solid Tumor (3)Cancer (3)Lung Cancer (3)Prostate Cancer (3)Thyroid Cancer (3)NSCLC (Non-small Cell Lung Cancer) (3)

Frequently Asked Questions — Clinical Trials in Oregon

How many clinical trials are currently recruiting in Oregon?
ClinicalMetric currently tracks 195 actively recruiting clinical trials with at least one location in Oregon. The total number of registered studies—including active but not currently enrolling trials—is 195. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Oregon?
Oregon hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Endometrial Cancer, Advanced Solid Tumor, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Oregon serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Oregon?
To join a clinical trial in Oregon, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Oregon maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Oregon

NCT06067438 Phase 2
Recruiting
Amiodarone for the Prevention of Atrial Fibrillation After Minimally Invasive Es...
Condition
Atrial Fibrillation
Enrollment
90 pts
Location
United States
Sponsor
OHSU Knight Cancer Institute
View Trial →
NCT05835310 Phase 3
Recruiting
An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus ...
Condition
Systemic Lupus Erythematosus
Enrollment
100 pts
Location
United States, Argentina, Brazil
Sponsor
AstraZeneca
View Trial →
NCT05436548 N/A
Recruiting
The Work-life Check-ins: a Supervisor-driven Intervention to Reduce Burnout in P...
Condition
Burnout
Enrollment
500 pts
Location
United States
Sponsor
Oregon Health and Science Univ
View Trial →
NCT06381674 N/A
Recruiting
Wearable Technology to Characterize and Treat mTBI Subtypes: Biofeedback-Based P...
Condition
Mild Traumatic Brain Injury, Concussion
Enrollment
100 pts
Location
United States
Sponsor
Oregon Health and Science Univ
View Trial →
NCT07382596 Phase 4
Recruiting
Cervical Plexus Hydrodissection With D5W Versus NS for Treatment-Resistant PTSD
Condition
PTSD
Enrollment
50 pts
Location
United States
Sponsor
Dr. Dean Reeves Clinic
View Trial →
NCT05136196 Phase 2
Recruiting
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Tr...
Condition
Clinical Stage III Cutaneous Melanoma AJCC v8
Enrollment
150 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT07265479 Phase 3
Recruiting
A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participant...
Condition
Atopic Dermatitis
Enrollment
180 pts
Location
United States, Canada
Sponsor
Organon and Co
View Trial →
NCT05775523 N/A
Recruiting
A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatro...
Condition
Growth Hormone Deficiency
Enrollment
500 pts
Location
United States
Sponsor
Ascendis Pharma Endocrinology
View Trial →
NCT05501262 N/A
Recruiting
Comparative Effectiveness of Cryoablation Versus Steroid and Lidocaine Alone for...
Condition
Morton Neuroma
Enrollment
32 pts
Location
United States
Sponsor
Oregon Health and Science Univ
View Trial →
NCT06172296 Phase 3
Recruiting
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Tre...
Condition
Ganglioneuroblastoma, Nodular
Enrollment
478 pts
Location
United States, Australia, Canada
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06158841 Phase 3
Recruiting
Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standa...
Condition
Multiple Myeloma
Enrollment
380 pts
Location
United States, Australia, Austria
Sponsor
AbbVie
View Trial →
NCT06672146 Phase 2
Recruiting
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia ...
Condition
Acute Myeloid Leukemia
Enrollment
93 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06787612 Phase 2
Recruiting
Investigation of Ubamatamab Combination Therapy in Adult Participants With Plati...
Condition
Ovarian Cancer
Enrollment
220 pts
Location
United States, Canada, South Korea
Sponsor
Regeneron Pharmaceuticals
View Trial →
NCT04566328 Phase 3
Recruiting
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Mu...
Condition
Plasma Cell Myeloma
Enrollment
1,450 pts
Location
United States, Puerto Rico
Sponsor
ECOG-ACRIN Cancer Research Gro
View Trial →
NCT07125027 N/A
Recruiting
A Multicomponent Intervention for Patients With Lumbosacral Radiculopathy: Move-...
Condition
Lumbosacral Radiculopathy
Enrollment
32 pts
Location
United States
Sponsor
National University of Natural
View Trial →
NCT06117254 N/A
Recruiting
Hearing Aids for Veterans With Functional Hearing Difficulties
Condition
Auditory Processing Disorder
Enrollment
142 pts
Location
United States
Sponsor
VA Office of Research and Deve
View Trial →
NCT07173751 Phase 3
Recruiting
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-N...
Condition
Breast Neoplasms
Enrollment
558 pts
Location
United States, Australia, Belgium
Sponsor
BioNTech SE
View Trial →
NCT06655246 Phase 1
Recruiting
A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gas...
Condition
Gastrointestinal Stromal Tumor (GIST)
Enrollment
157 pts
Location
United States
Sponsor
Kura Oncology, Inc.
View Trial →
NCT06501677 N/A
Recruiting
Using EMA Data to Inform a Web-intervention for Couples Concerned About Drinking
Condition
Alcohol; Use, Problem
Enrollment
275 pts
Location
United States
Sponsor
Stanford University
View Trial →
NCT05638581 Phase 3
Recruiting
Trauma Resuscitation With Low-Titer Group O Whole Blood or Products
Condition
Wounds and Injuries
Enrollment
1,100 pts
Location
United States
Sponsor
University of Alabama at Birmi
View Trial →
NCT07011719 Phase 3
Recruiting
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients...
Condition
Metastatic Clear Cell Renal Cell Carcinoma
Enrollment
720 pts
Location
United States, Australia, Canada
Sponsor
Arcus Biosciences, Inc.
View Trial →
NCT06780137 Phase 1, Phase 2
Recruiting
A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatama...
Condition
Small Cell Lung Cancer
Enrollment
327 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT07491172 Phase 1
Recruiting
A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractor...
Condition
Cardiovascular
Enrollment
90 pts
Location
United States, Australia, New Zealand
Sponsor
CRISPR Therapeutics AG
View Trial →
NCT07091019 N/A
Recruiting
A Real-world Chronic Myelogenous Leukemia (CML) Patient Disease Registry to Desc...
Condition
Chronic Myelogenous Leukemia - Chronic Phase
Enrollment
1,000 pts
Location
United States
Sponsor
Novartis Pharmaceuticals
View Trial →
NCT07356453 Phase 1
Recruiting
A Study of PARG Inhibitor FORX-428 in Patients With Advanced Solid Tumors.
Condition
Advanced Solid Tumors
Enrollment
40 pts
Location
United States
Sponsor
FoRx Therapeutics AG
View Trial →
Page 2 of 8 — 195 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology